CITADEL ADVISORS LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Protara Therapeutics, Inc. Common Stock, $0.001 par value per share (the "Shares") (TARA)

Filing Manager: CITADEL ADVISORS LLC
Reporting Manager: Kenneth Griffin
Security: Protara Therapeutics, Inc. Common Stock, $0.001 par value per share (the "Shares")
Symbol: TARA
Shares outstanding: 34,632,638 shares
Disclosed Ownership: 1,627,734 shares
Ownership: 4.7%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 18:24:06 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (7)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Citadel Advisors LLC	4.6%	1,612,531	1,612,531	/s/ Seth Levy	Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP	4.6%	1,612,531	1,612,531	/s/ Seth Levy	Seth Levy, Authorized Signatory
Citadel GP LLC	4.6%	1,612,531	1,612,531	/s/ Seth Levy	Seth Levy, Authorized Signatory
Citadel Securities LLC	0%	15,203	15,203	/s/ Guy Miller	Guy Miller, Authorized Signatory
Citadel Securities Group LP	0%	15,203	15,203	/s/ Guy Miller	Guy Miller, Authorized Signatory
Citadel Securities GP LLC	0%	15,203	15,203	/s/ Guy Miller	Guy Miller, Authorized Signatory
Kenneth Griffin	4.7%	1,627,734	1,627,734	/s/ Seth Levy	Seth Levy, attorney-in-fact*